Premarket trading shaped up as a mixed bag of earnings and regulatory updates, with biotech, software and consumer names among the movers. Biogen led the gains, rising about 4% after confirming its experimental Alzheimer’s drug will advance to a phase 3 trial, even though it fell short of the primary endpoint in the phase 2 study. The company said the drug demonstrated cognitive benefits.
According to CNBC, the broader moves spanned several corners of the market, including Versant Media Group, Yeti Holdings, Nvidia and Klarna, while crypto exchange Bullish was among the notable decliners after a disappointing quarterly report. Data show the premarket session reflecting both stronger results and cautious guidance across sectors.
Key takeaways
- Biogen up about 4% as its Alzheimer’s drug advances to phase 3 after a phase 2 miss, citing cognitive benefits.
- Versant Media Group up about 14.5% on quarterly results that showed revenue growth across content licensing and digital platforms; Adjusted EBITDA of $704 million, above the $608 million consensus.
- Yeti Holdings up roughly 10% after beating on both top and bottom lines in the first quarter; adjusted earnings 26 cents per share vs 18 cents expected; revenue $380.4 million vs $374.7 million forecast.
- Bullish tumbled about 9% after first-quarter results fell short of expectations on adjusted net income and revenue.
- Nvidia shares rose about 2% as Reuters reported U.S. clearance for sales of the H200 AI chip to roughly 10 Chinese firms, though delivery had not yet occurred.
- Cisco Systems jumped about 15% after third-quarter results and guidance exceeded expectations on both earnings and revenue; the company also announced job cuts.
- StubHub up about 14% following stronger-than-expected first-quarter revenue and adjusted EBITDA.
- Doximity down roughly 23% after guidance for current quarter and full year revenue disappointed analysts; quarterly adjusted earnings also came in below expectations.
- Jack in the Box +4% as second-quarter adjusted EBITDA beat expectations, though earnings and revenue missed consensus.
- Honda Motor rose about 3% in U.S.-listed shares after posting its first annual loss in decades due to restructuring costs, but maintaining a positive long-term outlook and dividend; full-year guidance for 2027 was above consensus.
- Viking Holdings up about 3.4% on first-quarter revenue surpassing estimates; reported a per-share loss in line with expectations.
- Klarna up around 16% after reporting first-quarter revenue of $1 billion, topping the $944.1 million consensus; operating income also reported.
What drove the move
Biogen’s stock move centered on an important clinical milestone. The company said its experimental Alzheimer’s therapy will proceed to a phase 3 trial, a step investors often treat as a potential path to broader market adoption even if a phase 2 outcome missed the primary endpoint. The company emphasised cognitive benefits as part of the rationale for continuing development, a factor that helped lift sentiment around the program.
Versant Media Group’s surge reflected stronger-than-expected quarterly results across its core content licensing and digital platforms. The company reported a solid first quarter and posted an adjusted EBITDA of $704 million, ahead of the roughly $608 million consensus compiled by analysts polled by FactSet. The revenue mix showed resilience in the company’s licensing and digital businesses, even as linear distribution for traditional pay-TV networks and advertising remained challenged.
Yeti Holdings’ rally followed a quarterly beat on both fronts. The outdoor-products maker reported adjusted earnings of 26 cents per share, versus an 18-cent consensus, and revenue of $380.4 million, topping the $374.7 million estimate. The results reinforced the strength of its premium outdoor categories and improved seasonal performance.
Bullish faced a harsher reaction after its Q1 results disappointed on both adjusted net income and revenue, suggesting the pace of growth in the crypto exchange segment remains a concern for investors weighing profitability against user growth and volume dynamics.
Nvidia’s small uptick came in the wake of Reuters reporting that the U.S. had cleared the sale of the H200 AI accelerator to approximately 10 Chinese firms, though no deliveries had yet occurred. The news kept Nvidia in focus as AI hardware demand remains a central market driver, with the potential for policy and export-control developments to shape near-term sentiment.
Cisco Systems’ 15% rise followed a strong quarterly print and an upbeat outlook that surpassed Wall Street expectations. The guidance implied a healthier revenue trajectory and margins than anticipated, even as the company indicated ongoing structural changes, including workforce reductions, to optimize its cost base.
StubHub’s surge reflected better-than-expected first-quarter revenue and EBITDA, underscoring the strength in its event-ticket ecosystem and related services as demand for live experiences remains robust.
Doximity’s share decline tracked softer current-quarter and full-year revenue guidance and a miss on quarterly earnings expectations, highlighting the sensitivity of healthcare information platforms to near-term revenue visibility and monetization timelines.
Jack in the Box posted a mixed set, with EBITDA beating estimates but overall earnings and revenue missing consensus, signaling a mixed read on the fast-food chain’s turnarounds in the near term.
Honda Motor’s stock move came despite reporting its first annual loss in almost seven decades, driven by roughly $9 billion in costs tied to restructuring its electric-vehicle business. The company’s full-year guidance for 2027 was still seen as above expectations, and its dividend was maintained, supporting a cautious bounce in U.S.-listed shares.
Viking Holdings advanced modestly as first-quarter revenue exceeded expectations, even as the firm reported a per-share loss aligned with forecasts, reflecting ongoing volatility in the cruise industry as it navigates post-pandemic demand patterns.
Klarna’s double-digit rise followed a revenue beat for the first quarter, with the company reporting $1 billion in revenue and operating income of $17 million, surpassing expectations on revenue and signaling continued momentum in the European-led payments group.
Market reaction
Across the premarket session, gains were concentrated in health care, software-enabled platforms and consumer services, while fintech and crypto-related names faced mixed to softer moves. The breadth of activity underscores a market weighing mixed earnings signals against a backdrop of ongoing macro and policy considerations. The moves also illustrate how different business models—drug development, digital media, live events, and digital payments—are responding to the earnings cadence and forward-looking guidance.
What analysts are saying
Analysts cited by FactSet and other data providers flagged the relative strength in certain franchises and the asymmetric risk in others. For example, Versant’s EBITDA outperformance suggests a durable cash-generation capability from its licensing and digital assets, even as traditional linear business lines remain under pressure. Cisco’s stronger guidance and cost-reduction plan reinforced expectations for a more resilient risk profile among large-cap software and networking peers. Conversely, Doximity’s softer revenue guidance reflected the challenges of growth-stage software platforms in monetizing healthcare data streams at scale, a theme echoed by several peers in the health tech space.
As is common ahead of big tech and consumer earnings cycles, analysts highlighted the sensitivity of sentiment to forward guidance and cost discipline. The breadth of outcomes—some beating on the top and bottom lines, others missing—helps outline a market that is discriminating on quality of earnings and the durability of the revenue base.
Bigger picture
The premarket activity mirrors a market balancing growth expectations with a cautious stance on near-term profitability and policy developments. The mix of gains in companies with clearer cash-flow visibility against losses in those facing tighter revenue guidance underscores a broader investor emphasis on earnings quality and ability to scale in a rapidly evolving macro backdrop. The AI and digital payments themes remain central, with policy signals and export controls continuing to factor into stock performance for technology and tech-adjacent names.
What to watch next: investors will be turning to the next wave of earnings and guidance from peers across software, health care technology, and consumer services, as well as any further updates on policy or regulatory aspects tied to AI hardware and digital payments. It will be crucial to see how these narratives evolve as the next batch of results hits the tape and as macro data frames the path for rates and inflation in the coming weeks.
